TITLE

A COMPARATIVE STUDY OF LEKHAN THERAPY IN THE MANAGEMENT OF STHOULYA (OBESITY)

AUTHOR(S)
Nayak, Annada Prasad
PUB. DATE
July 2012
SOURCE
International Journal of Research in Ayurveda & Pharmacy;Jul/Aug2012, Vol. 3 Issue 4, p508
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Obesity is the world's oldest metabolic disorder. The WHO now considers obesity to be a Global epidemic and a public health problem. Globally an estimated 300 million adults are now obese and many are overweight. Prominent health risks associated with obesity are hypertension, type-2 diabetes mellitus, dyslipidemia, stroke, gall bladder stone, osteoarthritis, respiratory problem etc. As per Ayurveda, Acharya Charak has counted Sthoulya under the eight varieties of impediments which are designated as Nindita Purusha. According to Chikitsa Sutra of this disease, Lekhan therapy is an important therapeutic measure in Sthoulya as said by Acharya Charka. Moreover lekhan basti is the other and most effective therapy in the management of Sthoulya. To assess the effect of lekhan therapy by two therapeutic modules, 24 Sthoulya patients were selected for this study and were divided into two groups. Group A patients were given 15 lekhan basti in alternate day. After completion of basti, lekhan vati was given for two months. In group B, patients were given lekhan vati for three months, which was selected from Ca.Su.4:9 as lekhaneeya dasemani and is added with Varun and Vidang. The effects of two therapeutic modules were assessed statistically based on the Performa prepared. This was a humble effort to compare the effect of lekhan basti and lekhan vati in the management of Sthoulya. In this study we have found that lekhan basti followed by lekhan vati was more effective in combating the disease than only lekhan vati therapy.
ACCESSION #
79450394

Tags: OBESITY -- Treatment;  AYURVEDIC medicine;  METABOLIC disorders -- Treatment;  COMPARATIVE studies;  HYPERTENSION;  OSTEOARTHRITIS;  DYSLIPIDEMIA

 

Related Articles

  • POHYBOV� INTERVENCE JAKOU SOUC�ST L�CEN� NADV�HY A OBEZITY. Podebradsk�, R. // Rehabilitation & Physical Medicine / Rehabilitace a Fyzikalni Le;Aug2011, Vol. 18 Issue 2, p50 

    This article contains new aspects of obesity as a disease and an insight into physical activity in treating obesity. Currently, obesity is the most frequent metabolic disease (9) and it is important to search for a common, effective application for its prevention and treatment. Ideally, for a...

  • Obesity in Preschoolers: Behavioral Correlates and Directions for Treatment. Kuhl, Elizabeth S.; Clifford, Lisa M.; Stark, Lori J. // Obesity (19307381);Jan2012, Vol. 20 Issue 1, p3 

    Nearly 14% of American preschoolers (ages 2-5) are obese (BMI = 95th percentile for age and gender), yet this group has received little attention in the obesity intervention literature. This review examines what is known about behavioral correlates of obesity in preschoolers and the...

  • Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Cao, Yihai // Nature Reviews Drug Discovery;Feb2010, Vol. 9 Issue 2, p107 

    Current pharmacotherapeutic options for treating obesity and related metabolic disorders remain limited and ineffective. Emerging evidence shows that modulators of angiogenesis affect the expansion and metabolism of fat mass by regulating the growth and remodelling of the adipose tissue...

  • Exercise and the fatty liver. Spassiani, Natasha A.; Kuk, Jennifer L. // Applied Physiology, Nutrition & Metabolism;Aug2008, Vol. 33 Issue 4, p802 

    Fatty liver is an increasingly prevalent condition that is associated with several metabolic derangements, thus necessitating the development of effective therapeutic interventions. Growing evidence from cross-sectional studies suggest that physical activity may be a promising therapy for fatty...

  • MEDICAL ESTABLISHMENT RECOGNIZES NEED TO SUPPRESS INSULIN.  // Life Extension;Sep2004, Vol. 10 Issue 9, p32 

    Reports that the article "Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders" was published in the June 2004 issue of "Current Medicinal Chemistry". Observation that insulin inhibitors can produce side effects and should not be taken on a daily basis;...

  • Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Murphy, Eileen F.; Cotter, Paul D.; Hogan, Aileen; O'Sullivan, Orla; Joyce, Andy; Fouhy, Fiona; Clarke, Siobhan F.; Marques, Tatiana M.; O'Toole, Paul W.; Stanton, Catherine; Quigley, Eamonn M. M.; Daly, Charlie; Ross, Paul R.; O'Doherty, Robert M.; Shanahan, Fergus // Gut;Feb2013, Vol. 62 Issue 2, p220 

    The article presents a study which reveals the working of two antimicrobials including the oral vancomycin and the bacteriocin producing probiotic and their impact in murine diet-induced obesity. In the process, laboratory mice were fed with high fat diet for 20 week with vancomycin and...

  • METABOLIC DISORDERS.  // MPR - Pharmacist's Edition;Spring2013, Vol. 7 Issue 1, p127 

    The article offers information on several drug prescriptions used for the treatment of metabolic disorders particularly obesity. It says that Adipex-P from Teva is used for short-term monotheraphy as adjunct in management of exogenous obesity. It states that Alli from GlaxoSmithKline is used to...

  • Capítulo1: Metabolismo energético. Krupa Das, Sai; B. Roberts, Susan // Conocimientos Actuales sobre Nutrición;2003, p3 

    The energetic equilibrium is adjusted by particularly sensitive mechanisms which have been identified during the present investigations. The disorders in the energetic equilibrium emerge from the genetic and environmental causes and explain many of the current common health problems in the...

  • Diabetes: Connectin' through adiponectin. Jones, Daniel // Nature Reviews Drug Discovery;Aug2003, Vol. 2 Issue 8, p606 

    Type 2, or adult-onset, diabetes mellitus is an increasing burden on Western health-care systems, and threatens to reach epidemic levels in developing countries. Adiponectin also known as 30-kDa adipocyte-related protein, an established antiatherogenic protein, has previously been implicated in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics